港股生物医药板块今日出现大涨行情,龙头股药明康德盘中股价飙升6.45%。分析人士指出,这是由于生物医药产业链整体表现强劲所致。
数据显示,港股多家生物医药公司股价今日全线走高,如康希诺生物、泰格医药等涨幅均超过4%。根据券商最新评级,近七成分析师对药明康德给予买入评级,表现最为看好。
此外,中信证券等大行预计,2025年医疗健康产业将持续活跃,创新药、CXO、生命科学、医疗器械及疫苗等细分产品线均获看好,因此建议重点布局头部公司。作为行业龙头代表,药明康德获资金大幅流入、引领行业走势符合预期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.